Français
ItalianoBond GlaxoSmithKline Holdings PLC 0.534% ( US377373AL97 ) in USD
| Issuer | GlaxoSmithKline Holdings PLC |
| Market price | 100 % ▲ |
| Country |  United Kingdom
|
| ISIN code |
 US377373AL97 ( in USD )
|
| Interest rate | 0.534% per year ( payment 2 times a year) |
| Maturity | 30/09/2023 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 1 250 000 000 USD |
| Cusip | 377373AL9 |
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Detailed description |
GlaxoSmithKline Capital PLC is a UK-based venture capital firm focused on life sciences investments, primarily supporting early-stage and growth-stage companies developing innovative therapies and technologies within GlaxoSmithKline's strategic areas of interest. GlaxoSmithKline Capital PLC's USD 1,250,000,000 0.534% bond (ISIN: US377373AL97, CUSIP: 377373AL9), issued in the United Kingdom, matured on September 30, 2023, with a final price of 100%, minimum purchase of 2000, and a semi-annual coupon payment, rated A by S&P and A2 by Moody's. |